Aetion

Acquired

Real-World Evidence Solutions | RWE Analytics

Headquarters
New York, New York
Employees
201–500
Founded
2013
Business Model
B2B
Website
aetion.com
Total Funding
$203.2M
Last Round
$110.0M Series CMay 2021
Rounds
3

About

Aetion is a healthcare technology company providing decision-grade real-world evidence software to biopharmaceutical manufacturers, payers, and regulatory agencies. Its platform includes Discover, Activate, Substantiate, and Generate products for RWE analysis. Aetion was acquired by Datavant in July 2025.

Tech & App Stack

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

View pricing

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

AcquisitionJul 2025
Series CSeries CMay 2021
Series BSeries BAug 2020
Series ASeries AMar 2017

Investors

Sign up to view investors

Create a free account to see which investors have funded this company.

Create Free Account

Similar Companies